<DOC>
	<DOCNO>NCT01873352</DOCNO>
	<brief_summary>The objective trial determine role renal sympathetic denervation prevention atrial fibrillation ( AF ) recurrence patient hypertension catheter-based AF ablation procedure plan . Patients randomize either AF catheter ablation ( usual therapy ) AF catheter ablation plus renal sympathetic denervation .</brief_summary>
	<brief_title>Renal Artery Denervation In Addition Catheter Ablation To Eliminate Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Age ≥ 18 year age History PAF plan guidelinesupported catheter ablation procedure . Paroxysmal AF define AF duration 30 sec 7 day . History significant hypertension ( define SBP ≥130 mm Hg and/or DBP ≥80 mmHg ) receive treatment least one antihypertensive medication Renal vasculature accessible determined preprocedural renal MRA Willingness comply postprocedural followup requirement sign inform consent Inability undergo AF catheter ablation ( e.g. , presence leave atrial thrombus , contraindication anticoagulation ) Prior leave atrial ablation atrial arrhythmia NYHA class IV congestive heart failure Pers longstanding Pers AF ( duration &gt; 7 day ) Renal artery anatomy ineligible treatment An estimate glomerular filtration rate ( eGFR ) &lt; 45mL/min/1.73m2 , use MDRD calculation Life expectancy &lt; 1 year medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>